News

4 1. FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or ...
Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal ...
FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma The Food and Drug Administration approved belzutifan, or Welireg, marketed by Merck (MRK), for adult and pediatric ...
"Without trials, it is only a matter of time before the FDA approves a vaccine that causes some bad outcome like vaccine-induced narcolepsy. If this happens, you can kiss faith in vaccines ...
But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal ...
Makary did not reveal any specific details about the upcoming framework, but said it will outline the FDA's approach to vaccine approvals, providing companies with a clearer understanding of ...
The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...
Shares rose 10% to $7.41 in premarket trading on Monday. The stock is down 21% on the year. The biotechnology company said the FDA approved the biologics license application for Nuvaxovid to prevent ...